# Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)

> **NCT01102543** · — · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 972 (actual)

## Conditions studied

- Respiratory Distress Syndrome, Newborn

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01102543
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-10
- **Final completion:** 2011-03
- **Target enrollment:** 972 (ACTUAL)
- **Last updated:** 2012-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102543, "Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01102543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*